US Patent 11337938 Epinephrine formulations
Patent 11337938 was granted and assigned to Par Pharmaceutical on May, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Matthew Kenney0
Suketu Sanghvi0
Vinayagam Kannan0
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 25 May, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+345 characters)
US Patent 11337938 Epinephrine formulations
Article
Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11337938
Date of patent
May 24, 2022
Patent application number
16817253
Date Filed
March 12, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11337938 Epinephrine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
